$XBI $135 -3%
Covid Updates
$MRNA +3% and $CTLT +1% expand collaboration. source
Pipeline Updates
$FGEN -31% Roxa update. source
$TMDX Halted for FDA adcom. source
$IMAB +5% 1st patient dosed ph 1. source
$GALT +25% launches NAVIGATEnash.com for patients and physicians. source
$SRRK -20% Ph 2 12-mo data. source
$LABP +8% IND accepted for BT-11. source
$SEEL -7% Partnership with $ATR device for SLS-002. source
$APTX -7% Recommences ph 2 study. source
Finance Updates
$FIXX -14% Offering. source
$SRNE -5% Acquisition of Acea Therapeutics. source
$KDNY -3% Update on non-renal programs from Aduro Bio merger. source
Comments